Receptor Ai
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
20-22 Wenlock Rd, London, Greater London...Website
www.receptor.aiRevenue
<$5 MillionIndustry
About Receptor Ai
Receptor Ai Org Chart
Is Receptor Ai your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Receptor Ai has new funding data
Click to see if Receptor Ai had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Receptor Ai
Check if Receptor Ai has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if Receptor Ai is spiking on competitors!
Product Launch: Get notified when Receptor Ai launches new products
Receptor Ai, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Receptor Ai recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Receptor Ai is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Receptor Ai is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Receptor Ai.
Receptor Ai Tech Stack
A closer look at the technologies used by Receptor Ai
Receptor Ai News & Media
PRISM BioLab and Receptor.AI Announce Drug Discovery Collaboration Agreement
— Advancing the Discovery of Novel Therapies and Building an Integrated Drug Discovery Platform by Combining PPI Science with AI — TOKYO, March 12, 2026 /PRNewswire/ -- PRISM BioLab Co., Ltd. ("PRISM") and Receptor.AI Inc. today announced that they have entered into a drug discovery...BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics
PHILADELPHIA and VANCOUVER, British Columbia and BOSTON, Nov. 20, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, has announces that its subsidiary, BriaPro Therapeutics Corp. (“BriaPro”), has initiated a research collaboration with Receptor.AI, an AI-driven drug discovery company, to design anti-cancer isoform-selectiveThe lipid membranes are druggable and available for AI-based drug design (acticle by Receptor.AI)
LONDON, UNITED KINGDOM, December 15, 2022 /EINPresswire.com/ -- Article 1: https://doi.org/10.3390%2Fpharmaceutics13040524 Article 2: https://doi.org/10.1016/j.bbadis.2022.166614 Are the lipid membranes druggable? Transmembrane proteins …Receptor.AI helps fight obesity by acting on the “sixth taste” receptors
LONDON, UNITED KINGDOM, December 12, 2022 /EINPresswire.com/ -- A full text of the article can be found via the link: Obesity is one of the health problems which seems to be minor in comparison to cancer or neurodegenerative disorders from an …
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Receptor Ai
RECEPTOR.AI is an innovative AI-driven drug discovery company that empowers pharmaceutical and biotech companies to accelerate the development of small molecule and peptide therapeutics. The platform comprises specialized workflows and advanced predictive AI models tailored to specific drug modalities, including small molecules, peptides, and proxi... Read More